Abstract:Chemodynamic therapy (CDT) produces highly toxic hydroxyl free radicals (•OH) to achieve selective tumor treatment based on Fenton reaction. However, the insufficient intracellular H 2 O 2 level in tumor cells severely limits the therapeutic efficacy of Fenton reaction. Here, we report a synergistic enhancement strategy for amplifying Fenton reaction and relieving the tumor immunosuppressive microenvironment . In this work, a targeted PCL-PEG-cRGD (PCE-cRGD) micelle was developed for delivering apatinib (APA) to tumor vessels, promoting vascular normalization and relieving tumor hypoxia . On one hand, the hypoxia relief promoted the chemodynamic therapy of ascorbyl palmitate-loaded FePOs, where ascorbyl palmitate generates endogenous H 2 O 2 in the presence of oxygen, and FePOs catalyze Fenton reaction to produce more potent •OH, which can be reduced to Fe 2+ by ascorbyl palmitate. The continued involvement of Fe 2+ in the Fenton reaction enhances tumor therapy efficiency through cyclic catalysis and self-enhanced catalysis. On the other hand, the increased oxygen content induced the polarization of M2 macrophage to antitumor M1 phenotype, which secreted TNF-α and IL-6 to activate CD4 + and CD8 + T cells, enhancing antitumor immune response. Combining enhanced chemodynamic therapy and immunotherapy, this strategy establishes the high feasibility of the synergistic treatment concept.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the efficacy of chemodynamic therapy (CDT) and immunotherapy in tumor ablation. Specifically, the research focuses on the following key issues: 1. **Insufficient H₂O₂ level in tumor cells**: Traditional CDT relies on the Fenton reaction to generate highly toxic hydroxyl radicals (•OH), but the H₂O₂ level in tumor cells is usually not sufficient to support an effective Fenton reaction, thus limiting the treatment effect. 2. **Tumor immunosuppressive microenvironment**: There are factors such as hypoxia, acidic environment, and immunosuppression in the tumor microenvironment. These factors not only hinder the effect of CDT but also suppress the anti - tumor activity of the immune system. To solve these problems, researchers proposed a synergistic enhancement strategy to improve the efficacy of CDT and immunotherapy in the following ways: - **Promote vascular normalization and relieve hypoxia**: Use targeted PCL - PEG - cRGD (PCE - cRGD) micelles to deliver apatinib (APA) to tumor blood vessels to promote vascular normalization and relieve tumor hypoxia. The relief of hypoxia helps to improve the efficiency of CDT and induces M2 macrophages to polarize towards the anti - tumor M1 phenotype, thereby activating CD4+ and CD8+ T cells and enhancing the anti - tumor immune response. - **Enhance the Fenton reaction**: FePOs nanoparticles loaded with ascorbyl palmitate (PA) release PA and FePOs after degradation in tumor cells. PA reacts with oxygen to generate endogenous H₂O₂, and Fe³⁺ is reduced to Fe²⁺ by PA, further reacting with H₂O₂ to generate more •OH, improving the tumor - killing effect through cyclic catalysis and self - enhancing catalysis. In summary, this study aims to synergistically enhance the efficacy of CDT and immunotherapy by regulating the tumor microenvironment, especially by relieving hypoxia and enhancing the Fenton reaction, so as to achieve more effective tumor ablation.

Enhanced chemodynamic therapy and immunotherapy by hypoxia augmentation for tumor ablation

Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation

Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief

HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy

A Positive Self-Amplified H2O2 and Acidity Circulation for Boosting CDT-PTT-starvation Therapy

Oxygen-Independent Radiodynamic Therapy: Radiation-Boosted Chemodynamics for Reprogramming the Tumor Immune Environment and Enhancing Antitumor Immune Response

Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation

Boosting Chemodynamic Therapy by Tumor-Targeting and Cellular Redox Homeostasis-Disrupting Nanoparticles.

Macrophage-membrane-coated hybrid nanoparticles with self-supplied hydrogen peroxide for enhanced chemodynamic tumor therapy

Ignored role of polyphenol in boosting reactive oxygen species generation for polyphenol/chemodynamic combination therapy

Boosting Chemodynamic Therapy via a Synergy of Hypothermal Ablation and Oxidation Resistance Reduction

Hypoxia‐Responsive Nanoscale Coordination Polymer Enhances the Crosstalk Between Ferroptosis and Immunotherapy

Tumor microenvironment-responsive intelligent nanoplatform with oxygen self-supply for synergistic chemotherapy/photodynamic therapy/photothermal therapy against hypoxic tumors

Boosting tumor treatment by dredging the hurdles of chemodynamic therapy synergistic ion therapy

Self-Amplified Activatable Nanoprodrugs for Enhanced Chemodynamic/Chemo Combination Therapy

Oncocyte Membrane-Camouflaged Multi-Stimuli-Responsive Nanohybrids for Synergistic Amplification of Tumor Oxidative Stresses and Photothermal Enhanced Cancer Therapy

Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy

Biodegradable nanotherapeutic with simultaneously GSH depletion and H 2 O 2 supplying for enhanced synergistic chemotherapy/chemodynamic therapy

Tumor Microenvironment-Responsive and Catalytic Cascade-Enhanced Nanocomposite for Tumor Thermal Ablation Synergizing with Chemodynamic and Chemotherapy

Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules

Enhanced Transcutaneous Chemodynamic Therapy for Melanoma Treatment through Cascaded Fenton-like Reactions and Nitric Oxide Delivery